Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
暂无分享,去创建一个
R Kucherlapati | R. Kucherlapati | R. Shprintzen | B. Morrow | R. Kucherlapati | H. Lachman | D. Papolos | H M Lachman | B Morrow | R Shprintzen | S Veit | S S Parsia | G Faedda | R Goldberg | D F Papolos | R. Goldberg | G. Faedda | S. Veit | S. Parsia | Sabine Veit
[1] J. Axelrod,et al. Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.
[2] R. Fieve,et al. Erythrocyte catechol-o-methyltransferase activity in primary affective disorder. , 1977, Biological psychiatry.
[3] B. Herjanic,et al. Differentiating psychiatrically disturbed children on the basis of a structured interview , 1977, Journal of abnormal child psychology.
[4] R. Weinshilboum,et al. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. , 1977, American journal of human genetics.
[5] R. Shprintzen,et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. , 1978, The Cleft palate journal.
[6] R. Weinshilboum,et al. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. , 1979, Science.
[7] J. Hoo,et al. Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses , 1981, Psychiatry Research.
[8] R. Weinshilboum,et al. Genetics of red cell COMT activity: analysis of thermal stability and family data. , 1981, American journal of medical genetics.
[9] M. Załuska,et al. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness , 1983, Acta psychiatrica Scandinavica.
[10] M. Załuska,et al. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness , 1983, Acta psychiatrica Scandinavica.
[11] R. Tissot,et al. The decrease of erythrocyte catechol‐O‐methyltransferase activity in depressed patients and its diagnostic significance , 1987, Acta psychiatrica Scandinavica.
[12] R. Weinshilboum,et al. Human liver catechol‐O‐methyltransferase pharmacogenetics , 1990, Clinical pharmacology and therapeutics.
[13] Z Dembic,et al. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Jalanko,et al. Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA , 1991 .
[15] R. Shprintzen,et al. Late-onset psychosis in the velo-cardio-facial syndrome. , 1992, American journal of medical genetics.
[16] D. Diehl,et al. The role of dopamine in mood disorders. , 1992, Comprehensive psychiatry.
[17] R. Shprintzen,et al. The velo-cardio-facial syndrome is associated with chromosome 22 deletions which encompass the DiGeorge syndrome locus , 1992 .
[18] B. Emanuel,et al. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. , 1992, Genomics.
[19] R. Shprintzen,et al. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus , 1992, The Lancet.
[20] R. Shprintzen,et al. Velo-cardio-facial syndrome: a review of 120 patients. , 1993, American journal of medical genetics.
[21] I. Dunham,et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. , 1993, Human molecular genetics.
[22] S. Aksoy,et al. Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples. , 1993, Pharmacogenetics.
[23] R. Weksberg,et al. Velo-cardio-facial syndrome and psychotic disorders: implications for psychiatric genetics. , 1994, American journal of medical genetics.
[24] T. Kiviluoto,et al. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European journal of biochemistry.
[25] D. Housman,et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. , 1994, The Journal of nervous and mental disease.
[26] I. Ulmanen,et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.
[27] L. Cottler,et al. Computerized interviews as a method of assessing psychopathology in children. , 1995, Comprehensive psychiatry.
[28] I. Dunham,et al. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. , 1995, American journal of human genetics.
[29] N J Cox,et al. Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.
[30] R. Kucherlapati,et al. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. , 1995, American journal of medical genetics.
[31] L. Altshuler. Premenstrual Dysphonias: Myths and Realities , 1995 .
[32] L. Altshuler,et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. , 1995, The American journal of psychiatry.
[33] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[34] W. Reich,et al. Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms , 1982, Journal of abnormal child psychology.